Flo Bio
Other, 3401 Grays Ferry Ave, Philadelphia, Pennsylvania, 19146, United States, 1-10 Employees
Phone Number: +12*********
Who is FLOBIO
FloBio is pioneering a novel point of care (POC) blood diagnostic platform that assesses blood biology and clotting status under physiologic, dynamic flow. Our proprietary microfluidic te...
Read More
-
Headquarters: 3401 Grays Ferry Ave, Philadelphia, Pennsylvania, 19146, United States
-
Date Founded: 2017
-
Employees: 1-10
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
SIC Code: 
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding FloBio
Answer: FloBio's headquarters are located at 3401 Grays Ferry Ave, Philadelphia, Pennsylvania, 19146, United States
Answer: FloBio's phone number is +12*********
Answer: FloBio's official website is https://flobiollc.com
Answer: FloBio's revenue is $1 Billion and Over
Answer: FloBio's SIC: 8043
Answer: FloBio's NAICS: 621399
Answer: FloBio has 1-10 employees
Answer: FloBio is in Other
Answer: FloBio contact info: Phone number: +12********* Website: https://flobiollc.com
Answer: FloBio is pioneering a novel point of care (POC) blood diagnostic platform that assesses blood biology and clotting status under physiologic, dynamic flow. Our proprietary microfluidic technology is designed to set a new standard for monitoring blood function in emergency critical care settings. Rapid and real-time measurements precisely identify the clotting defects, enabling clinicians to personalize management of bleeding and thrombotic risk. The results is fewer complications, improved clinical outcomes and reduced health care costs. Problem Early identification and corrective treatment of clotting defects is necessary for effective management of bleeding and thrombotic risk in emergency, critical care settings. Bleeding and clotting deficiencies are major contributing factors to the 5 million trauma injury fatalities worldwide. In addition, with over 5 million DOAC patients in the US, there are a growing number of patients finding themselves in emergent situations and at risk for or experiencing major bleeds. Current tests such as lab based clotting tests and emerging point of care viscoelastic tests are time consuming and provide limited information to physicians who need to quickly make treatment decisions based on clotting function. In some cases there can be an inability or delay in personalized treatment and correction of the clotting defect. This can lead to increased patient risk, greater exposure to transfusion or blood products, complications, long-term disability and mortality. FloBio offers a microfluidic based technology built upon innovations in device manufacturing and multiplex analysis of blood hemodynamics and clotting metrics. The FloBio diagnostic system utilizes dynamic blood flow to rapidly and accurately identify clotting deficiencies, providing clinicians with comprehensive and actionable information to personalize treatment.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month